Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Open in API
Filings indexed 817 across all filing types
Latest filing 2022-04-08 Board/Management Inform…
Country IT Italy
Listing XMIL DIA

About Diasorin

https://diasoringroup.com/en

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
Publication of the lists of candidates for the appointment of the Board of Director, of the Board of Statutory Auditors and resolution proposals
Board/Management Information Classification · 95% confidence The document is an official announcement from DiaSorin dated April 8, 2022, regarding the upcoming Shareholders' meeting on April 29, 2022. The subject explicitly states: 'Publication of the lists of candidates for the appointment of the Board of Director, of the Board of Statutory Auditors and resolution proposals'. This content relates directly to the nominations and proposals being put forward for shareholder voting at a general meeting. This strongly aligns with the purpose of materials distributed before or related to a general meeting, such as proxy statements or governance disclosures. Since the document details the lists of candidates for the Board and Auditors, it is highly relevant to the governance structure and the voting process. While it is an announcement, the core content is the publication of candidate lists for appointments, which is a key component of the materials presented at an AGM. Given the options, this is most closely related to the materials prepared for the Annual General Meeting (AGM-R) or potentially Governance Information (CGR). However, because it specifically concerns the lists of candidates for appointment to the Board and Auditors ahead of the meeting, AGM-R (AGM Information) is the most precise fit, as these lists are central to the AGM agenda items (items 3 and 4 mentioned in the text). It is not a DEF 14A (Remuneration) or a DVA (Declaration of Voting Results), but the preparatory material for the vote.
2022-04-08 English
Pubblicazione delle liste per la nomina del Consiglio di Amministrazione, del Collegio Sindacale e delle relative proposte di delibera
Board/Management Information Classification · 95% confidence The document is an official regulatory announcement (Informazione Regolamentata) dated April 8, 2022, regarding the upcoming Shareholders' Meeting (Assemblea degli Azionisti) on April 29, 2022. The core content details the submission of candidate lists for the nomination of the Board of Directors (Consiglio di Amministrazione) and the Board of Statutory Auditors (Collegio Sindacale), along with related proposals for deliberation (proposte di delibera). This content directly relates to the procedures and materials required for a general meeting, specifically concerning the election of governing bodies. This aligns most closely with the purpose of materials distributed to solicit votes or provide information leading up to a shareholder meeting, which falls under Proxy Solicitation & Information Statement (PSI). While it mentions the AGM date, the primary focus is the presentation of candidate lists, which is a key component of proxy materials. It is not the AGM presentation itself (AGM-R), nor is it a general earnings report (ER/IR). Since it provides specific information required for shareholders to vote on board appointments, PSI is the most precise fit.
2022-04-08 Italian
Update Annual Calendar of Corporate Events 2022
Report Publication Announcement Classification · 99% confidence The document is a formal notification from DiaSorin S.p.A. dated April 8, 2022, titled 'Update Annual Calendar of Corporate Events 2022'. It lists scheduled dates for key corporate activities, including the approval of quarterly results, the Half-Yearly Financial Report, the Annual General Meeting (AGM), and potential dividend payment timing. Since the document's primary function is to announce the schedule of future corporate events and reports (like the AGM and financial report approvals), and it is very short (under 5,000 characters) and refers to other future documents, it fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given that it specifically announces the schedule for the AGM and the release of financial reports, RPA is a strong candidate, but since it is a general update on the calendar rather than announcing the immediate publication of a specific report, and it contains information about the AGM and dividend timing, it is best classified as a general regulatory announcement that doesn't fit the specific report codes. However, looking closely at the content, it announces the date for the AGM and the approval of financial reports. If the document were the AGM material itself, it would be AGM-R. If it were the financial report, it would be IR or 10-K. Since it is merely announcing the *schedule* of these events, it is a regulatory announcement. Given the options, RPA (Report Publication Announcement) is suitable as it announces the publication schedule of future reports. Alternatively, RNS (Regulatory Filings) is the fallback. Since it is a structured update on corporate events, RPA seems slightly more specific than the general RNS fallback, although RNS is also plausible for non-standard announcements. I will choose RPA as it announces the timing of future report publications.
2022-04-08 English
Aggiornamento Calendario Annuale Eventi Societari 2022
Report Publication Announcement Classification · 99% confidence The document is an official regulatory announcement (Informazione Regolamentata) from DiaSorin dated April 8, 2022. The subject ('Oggetto') is 'Aggiornamento Calendario Annuale Eventi Societari 2022' (Update to the Annual Calendar of Corporate Events). It details scheduled dates for Board meetings (approving quarterly/semi-annual results) and the Shareholders' Meeting (Assemblea degli Azionisti) for approving the 2021 Financial Statements and renewing management bodies. It also mentions the expected month for dividend payment. Since this document primarily announces the schedule and dates for future corporate events, including the AGM and financial report releases, it is best classified as a general regulatory announcement that updates the market on corporate governance and reporting timelines. Given the content focuses heavily on the schedule for the Annual General Meeting (AGM) and the release of annual/interim reports, it is closely related to AGM/Shareholder events and general corporate scheduling. However, it is not the AGM presentation itself (AGM-R), nor is it the full Annual Report (10-K) or a specific Dividend Notice (DIV). It is an announcement *about* future corporate events. The closest fit among the specific codes that deal with shareholder meetings or corporate schedules is AGM-R (if it were the presentation) or RPA (Report Publication Announcement, as it announces future publications). Since it is a calendar update including the AGM date and other key dates, and it is a formal regulatory filing ('REGEM'), the most appropriate classification for a general update on corporate events and schedules, especially those involving shareholder meetings, is often captured under a general regulatory announcement or one related to shareholder meetings. Given the explicit mention of the 'Assemblea degli Azionisti' (Shareholders' Meeting) date and agenda items (approving financials, remuneration policy, renewal of bodies), it strongly relates to shareholder governance. However, as a pure calendar update, it fits well under RPA (Report Publication Announcement) or RNS (Regulatory Filings). Since it announces the date for the AGM, and the AGM is a key event, I will check if any other code fits better. It is not a DIV, not an ER, not a 10-K. It is an announcement of future events. RPA (Report Publication Announcement) is for announcing the *publication* of reports. This announces the *schedule* of events, including the AGM. Given the comprehensive nature of the schedule update, and the lack of a specific 'Corporate Calendar Update' code, RNS (Regulatory Filings) is the safest fallback, but RPA is also plausible as it announces the timing of future report publications. Considering the focus on the AGM date and agenda, and the fact that it is a formal regulatory filing ('REGEM'), I will classify it as a general Regulatory Filing (RNS) as it is a broad update on corporate governance timelines rather than a specific report or a direct proxy solicitation document.
2022-04-08 Italian
Pubblicazione della Relazione Finanziaria Annuale e documenti correlati
Report Publication Announcement Classification · 99% confidence The document is a formal announcement from DiaSorin S.p.A. dated April 7, 2022. The subject line explicitly states: 'Pubblicazione della Relazione Finanziaria Annuale e documenti correlati' (Publication of the Annual Financial Report and related documents). The text confirms that the 'Relazione Finanziaria Annuale' (Annual Financial Report), which includes the draft financial statements for 2021, the management report, and the non-financial statement, has been made available to the public. Since the document itself is an announcement stating that the full report is attached or available elsewhere, and it is short (3977 chars), it fits the criteria for a Report Publication Announcement (RPA) rather than the full Annual Report (10-K) or Interim Report (IR).
2022-04-07 Italian
Relazione sulla politica in materia di remunerazione per l'esercizio 2022 e sui compensi corrisposti nell'esercizio 2021
Remuneration Information Classification · 100% confidence The document title is "RELAZIONE SULLA POLITICA IN MATERIA DI REMUNERAZIONE PER L'ESERCIZIO 2022 E SUI COMPENSI CORRISPOSTI NELL'ESERCIZIO 2021 DI DIASORIN S.p.A." (Report on the Remuneration Policy for the year 2022 and on the Compensation paid in the year 2021 of DiaSorin S.p.A.). This explicitly indicates a report detailing executive and director compensation policies and actual pay, which aligns perfectly with the definition of Remuneration Information (DEF 14A). Furthermore, the table of contents includes sections like "Executive Summary - Politica Retributiva 2022" (Executive Summary - Remuneration Policy 2022) and sections detailing the remuneration of management and control bodies, confirming the subject matter.
2022-04-07 Italian

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.